Abbott Laboratories (ABT) Total Liabilities (2009 - 2026)
Abbott Laboratories (ABT) posted Total Liabilities of $109.2 billion for Q2 2026, down 1.1% sequentially from $110.4 billion in Q1 2026, and up 30.02% YoY from $84.0 billion in Q2 2025.
Abbott Laboratories (ABT) Total Liabilities (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Total Liabilities for 18 years, with the latest figure at $109.2 billion in Q2 2026.
- Quarterly Total Liabilities rose 30.02% year-over-year to $109.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $109.2 billion (up 30.02% YoY) and the FY2025 annual result came in at $86.7 billion, up 6.51% from the prior year.
- Total Liabilities retreated to $109.2 billion in Q2 2026 per ABT's latest filing, from $110.4 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $110.4 billion in Q1 2026 and troughed at $22.3 billion in Q4 2022.
- A 5-year average of $77.4 billion and a median of $74.1 billion in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities surged 227.77% in 2023, then fell 1.8% in 2024.
- Over 5 years, Total Liabilities stood at $22.3 billion in 2022, then soared by 227.77% to $73.2 billion in 2023, then advanced by 11.2% to $81.4 billion in 2024, then increased by 6.51% to $86.7 billion in 2025, then gained by 25.95% to $109.2 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $109.2 billion, $110.4 billion, and $86.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | 10.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.22 Bn |
| Mar 31, 2026 | 110.43 Bn |
| Dec 31, 2025 | 86.71 Bn |
| Sep 30, 2025 | 84.18 Bn |
| Jun 30, 2025 | 84.00 Bn |
| Mar 31, 2025 | 81.45 Bn |
| Dec 31, 2024 | 81.41 Bn |
| Sep 30, 2024 | 74.36 Bn |
| Jun 30, 2024 | 73.02 Bn |
| Mar 31, 2024 | 72.47 Bn |
| Dec 31, 2023 | 73.21 Bn |
| Sep 30, 2023 | 72.09 Bn |
| Jun 30, 2023 | 73.35 Bn |
| Mar 31, 2023 | 73.79 Bn |
| Dec 31, 2022 | 22.34 Bn |
| Sep 30, 2022 | 72.80 Bn |
| Jun 30, 2022 | 74.20 Bn |
| Mar 31, 2022 | 74.01 Bn |
| Dec 31, 2021 | 21.17 Bn |
| Sep 30, 2021 | 73.80 Bn |